GSK
9 posts
Merck (NYSE: MRK) stopped its clinical study for Vorapaxar, its cardiovascular drug developed to treat patients with acute coronary syndrome. The announcement issued by MRK mentions that the trial is going to continue for those patients who do not have acute coronary syndrome but have either had a previous heart […]
Model Manager trade activity, September 20th 2010 Covestor Model Manager Rebound Trading traded PFF in their Model Rebound ETF Covestor Model Manager Rebound
Author: Vivian LewisDisclaimer: Vivian currently owns GSK in her Covestor International Yield Model. Mellanox (NYSE: MLNX) is the Israeli maker of connectivity devices for servers, ethernet and financial data centers, storage systems, cloud computing, and supercomputers. On July 21, 2010 MLNX reported after the market close 2Q2010 revenues at $40 […]
Covestor.com’s model manager Vivian Lewis offers her daily international briefing. Note that not all companies are held in the International Yield Covestor Model. Rather, some are just International Companies that Vivian tracks. Followed Securities Disclaimer: Vivian currently owns GSK, CVE and BCS in her Covestor Top International Model. The value […]
Covestor.com’s model manager Vivian Lewis offers her daily international briefing. Disclaimer: in her International Yield Covestor Model, Vivian owns GSK and BLX. VIT, WILC and NABI are currently not owned in the Covestor International Model. Rather, these are just International Companies that Vivian tracks. The burden hanging over Glaxo Smith […]
Covestor model manager Vivian Lewis offers her daily international briefing. Note that not all companies are held in the International Yield Covestor Model. Rather, some are just International Companies that Vivian tracks. Market Update for Tuesday July 19th, 2010 US data is actually expected to be woeful. Especially existing home […]